Mast Therapeutics (MSTX) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts MSTX Hot Sheet
Join SI Premium – FREE
Mast Therapeutics (NYSE: MSTX) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06).
For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citizens launches transportation coverage, names FedEx a top large-cap pick
- Progressive Corp. (PGR) Reports Q2 EPS of $5.67
- SemiLEDS (LEDS) Tops Q3 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
